Acrosomal vesicle exocytosis

pathway activity — cross-omics
GO:0060478Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Acrosomal vesicle exocytosis pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CRY2, MLYCD, and DIRAS2, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Acrosomal vesicle exocytosis activity versus CRY2 in BRCA (Pearson r = 0.12).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCACRY2 →+0.496+0.673.009.00335
GBMMLYCD →+0.487+0.935<.001<.00135
GBMDIRAS2 →+1.193+0.804<.001<.00135
GBMTOX3 →+1.264+0.942<.001<.00134
GBMPDE1A →+1.040+0.883<.001<.00134
BRCAC1orf21 →+1.016+0.792<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0060478 vs CRY2 — BRCA

Per-sample scatter of Acrosomal vesicle exocytosis activity vs CRY2 in BRCA.

Explore this scatter interactively →

Exploration